Elizabeth Yamashita
Keine laufenden Positionen mehr
Karriereverlauf von Elizabeth Yamashita
Ehemalige bekannte Positionen von Elizabeth Yamashita
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SAVIENT PHARMACEUTICALS INC | Corporate Officer/Principal | 01.12.2012 | 01.01.2014 |
| SAVIENT PHARMACEUTICALS INC | Corporate Officer/Principal | 01.06.2011 | 01.10.2012 |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 01.05.2006 | 01.06.2011 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.01.2000 | 01.01.2006 |
| OUTLOOK THERAPEUTICS, INC. | General Counsel | 01.07.2015 | - |
Ausbildung von Elizabeth Yamashita
| Rochester Christian University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
Operativ
| Corporate Officer/Principal | 4 |
| General Counsel | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| OUTLOOK THERAPEUTICS, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Savient Pharmaceuticals, Inc.
 Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Savient Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products. The company focuses on developing and commercializing KRYSTEXXA for the treatment of chronic gout in adult patients who do not respond to conventional therapy. It also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. The company was founded in 1980 is headquartered in East Brunswick, NJ. | Health Technology |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
- Börse
- Insiders
- Elizabeth Yamashita
- Erfahrung
